{
    "clinical_study": {
        "@rank": "147906", 
        "arm_group": [
            {
                "arm_group_label": "verum tDCS", 
                "arm_group_type": "Experimental", 
                "description": "left-hemispheric tDCS: anode placed midway between F3 and FP1, cathode placed midway between T3 and P3"
            }, 
            {
                "arm_group_label": "sham tDCS", 
                "arm_group_type": "Sham Comparator", 
                "description": "left-hemispheric sham tDCS: anode placed midway between F3 and FP1, cathode placed midway between T3 and P3"
            }
        ], 
        "brief_summary": {
            "textblock": "The current study investigates the basic principles that underlie the efficacy of\n      transcranial direct current stimulation for chronic auditory verbal hallucinations in\n      schizophrenia in a multimodal design."
        }, 
        "brief_title": "Non-invasive Brain Stimulation for Auditory Verbal Hallucinations in Schizophrenia", 
        "condition": [
            "Auditory Verbal Hallucinations", 
            "Schizophrenia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hallucinations", 
                "Schizophrenia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diagnosis of schizophrenia\n\n          -  chronic auditory verbal hallucinations\n\n          -  right-handed\n\n        Exclusion Criteria:\n\n          -  drug abuse other than nicotine\n\n          -  severe cognitive deficits\n\n          -  severe medical conditions\n\n          -  severe neurological disorders\n\n          -  severe microangiopathy\n\n          -  history of electroconvulsive therapy\n\n          -  pregnancy or lactation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01801787", 
            "org_study_id": "EA4/123/12"
        }, 
        "intervention": {
            "arm_group_label": [
                "verum tDCS", 
                "sham tDCS"
            ], 
            "description": "active vs. sham tDCS left hemisphere", 
            "intervention_name": "tDCS", 
            "intervention_type": "Device", 
            "other_name": "device: neuroConn tDCS PLUS device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 22, 2014", 
        "location": [
            {
                "contact": {
                    "email": "andres.neuhaus@charite.de", 
                    "last_name": "Andres H. Neuhaus, MD", 
                    "phone": "00493084458412"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "14050"
                    }, 
                    "name": "Charit\u00e9 University Medicine"
                }, 
                "investigator": {
                    "last_name": "Andres H. Neuhaus, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "robert.lindenberg@charite.de", 
                    "last_name": "Robert Lindenberg, MD", 
                    "phone": "0049450560365"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "10117"
                    }, 
                    "name": "Charit\u00e9 University Medicine"
                }, 
                "investigator": {
                    "last_name": "Robert Lindenberg, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Mechanism of Non-invasive Brain Stimulation for Therapy of Chronic Auditory Verbal Hallucinations in Schizophrenia", 
        "other_outcome": [
            {
                "description": "N1 suppression during talking and listening will be assessed at baseline; change thereof at 3 days after intervention is further outcome measure", 
                "measure": "N1 suppression during talking and listening", 
                "safety_issue": "No", 
                "time_frame": "baseline; 3 days after intervention"
            }, 
            {
                "description": "Fractional anisotropy of longitudinal superior fascicle and arcuate fascicle will be assessed at baseline; change thereof 3 days after intervention is further outcome measure", 
                "measure": "Diffusion Tensor Imaging: Fractional anisotropy of longitudinal superior fascicle and arcuate fascicle", 
                "safety_issue": "No", 
                "time_frame": "baseline; 3 days after intervention"
            }, 
            {
                "description": "Default Mode Network connectivity will be assessed at baseline; change thereof 3 days after intervention is further outcome measure", 
                "measure": "Default Mode Network connectivity", 
                "safety_issue": "No", 
                "time_frame": "baseline; 3 days after intervention"
            }
        ], 
        "overall_contact": {
            "email": "andres.neuhaus@charite.de", 
            "last_name": "Andres H. Neuhaus, MD", 
            "phone": "00493084458412"
        }, 
        "overall_official": [
            {
                "affiliation": "Department of Neurology, Charit\u00e9 University Medicine Berlin", 
                "last_name": "Robert Lindenberg, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Psychiatry, Charit\u00e9 University Medicine Berlin", 
                "last_name": "Andres H. Neuhaus, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Auditory Hallucination Rating Scale score will be assessed at baseline; changes thereof at 3 days after intervention and 3 months after intervention are primary outcome measures", 
            "measure": "Change of Auditory Hallucination Rating Scale score", 
            "safety_issue": "No", 
            "time_frame": "baseline; 3 days after intervention; 3 months after intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01801787"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Charite University, Berlin, Germany", 
            "investigator_full_name": "Andres Neuhaus", 
            "investigator_title": "M.D.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Positive And Negative Syndrome Scale score will be assessed at baseline; changes thereof at 3 days after intervention and 3 months after intervention are secondary outcome measures", 
            "measure": "Positive And Negative Syndrome Scale", 
            "safety_issue": "No", 
            "time_frame": "baseline; 3 days after intervention; 3 months after intervention"
        }, 
        "source": "Charite University, Berlin, Germany", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Charite University, Berlin, Germany", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}